Castle Biosciences, Inc. Share Price
Stocks
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.00 USD | +4.52% |
|
+13.43% | -28.02% |
| 07-31 | Castle Biosciences, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Earnings Flash (CSTL) Castle Biosciences Posts Q2 Revenue of $103.5 Million, vs. FactSet Est of $86.2 Million | MT |
| Market Cap | 855M 744M 692M 635M 1.2B 81.66B 1.22B 8.16B 3.2B 40.65B 3.21B 3.14B 136B | P/E 2026 * |
-19.8x | P/E 2027 * | -26.1x |
|---|---|---|---|---|---|
| Enterprise Value | 581M 505M 470M 432M 816M 55.5B 828M 5.54B 2.18B 27.63B 2.18B 2.14B 92.64B | EV / Sales 2026 * |
1.59x | EV / Sales 2027 * | 1.51x |
| Free-Float |
96.57% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Castle Biosciences, Inc.
| 1 day | +4.52% | ||
| 1 week | +13.43% | ||
| 1 month | +17.40% | ||
| 3 months | +14.33% | ||
| 6 months | -28.92% | ||
| Current year | -28.02% |
| 1 week | 23.73 |  | 30.81 |
| 1 month | 22.46 | | 30.81 |
| Current year | 17.72 | | 44.28 |
| 1 year | 14.59 | | 44.28 |
| 3 years | 12.07 | | 44.28 |
| 5 years | 9.26 | | 78.58 |
| 10 years | 9.26 | | 107.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
CEO | Chief Executive Officer | 64 | 31/08/2007 |
Franklin Stokes
DFI | Director of Finance/CFO | 56 | 30/11/2017 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
BRD | Director/Board Member | 64 | 31/08/2007 |
Daniel Bradbury
CHM | Chairman | 64 | 31/08/2014 |
G. Cole
BRD | Director/Board Member | 70 | 05/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/07/26 | Fiscal year | Founder | 22,264 | 0.0734% | ||
| 14/07/26 | Fiscal year | Founder | 5,272 | 0.0174% | ||
| 01/07/26 | Sell | Chief Operating Officer | -8,586 | 0.0283% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.52% | +13.43% | +84.82% | +66.17% | 855M | |
| +6.33% | +9.95% | +295.29% | +315.15% | 21.74B | |
| -3.83% | -1.14% | -45.07% | -29.17% | 9.38B | |
| -1.35% | -4.94% | +39.96% | +15.20% | 6.49B | |
| -4.37% | +2.16% | +251.45% | -24.94% | 6B | |
| -1.81% | -0.93% | -13.78% | -15.42% | 5.57B | |
| -2.61% | +0.97% | -44.20% | - | 4.43B | |
| +4.21% | +7.67% | -16.15% | -29.58% | 4.38B | |
| +9.99% | +1.30% | +75.99% | +91.71% | 4.25B | |
| -1.02% | +5.24% | -16.77% | -40.86% | 2.8B | |
| Average | +1.01% | +2.83% | +61.15% | +38.69% | 6.59B | |
| Weighted average by Cap. | +1.62% | +3.55% | +117.93% | +108.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 366M 318M 296M 272M 514M 34.97B 522M 3.49B 1.37B 17.41B 1.38B 1.35B 58.38B | 399M 347M 323M 297M 560M 38.11B 569M 3.81B 1.49B 18.97B 1.5B 1.47B 63.62B |
| Net income | -42.94M -37.33M -34.74M -31.9M -60.24M -4.1B -61.17M -410M -161M -2.04B -161M -158M -6.84B | -29.72M -25.83M -24.04M -22.08M -41.69M -2.84B -42.33M -283M -111M -1.41B -112M -109M -4.74B |
| Net Debt | -274M -238M -222M -204M -384M -26.16B -390M -2.61B -1.03B -13.02B -1.03B -1.01B -43.67B | -252M -219M -204M -187M -353M -24.05B -359M -2.4B -943M -11.98B -946M -926M -40.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | US$28.00 | +4.52% | 1,757,839 |
| 30/07/26 | US$26.79 | +9.53% | 716,332 |
| 29/07/26 | US$24.46 | +2.39% | 340,083 |
| 28/07/26 | US$23.89 | -2.25% | 366,214 |
| 27/07/26 | US$24.44 | -0.99% | 291,638 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CSTL Stock
Select your edition
All financial news and data tailored to specific country editions
